Apr 18, 2013 09:30AM Regeneron Announces Upcoming 2013 Investor Conference Presentations

Jan 15, 2013 02:23PM Baird Releases Bullish Note on Regeneron (REGN), Eylea Taking Share

Oct 16, 2012 03:38PM Regeneron (REGN) Could Benefit as Avastin Suffers as Result of Meningitis Outbreak

Oct 4, 2012 12:54PM Baird Boosts Price Target on Regeneron (REGN) as Survey Indicates Positive Eylea Momentum

Apr 25, 2012 11:05AM Baird Maintains an 'Outperform' on Regeneron Pharma (REGN); Still Taking Share AND Growing the Branded Market

Mar 29, 2012 03:24PM Baird Reiterates a 'Outperform' on Regeneron Pharma (REGN); Bullish Thesis Intact

Mar 27, 2012 08:26AM Baird Sees More Upside on Regeneron Pharma (REGN), Lifts Price Target

Mar 21, 2012 12:14PM Streetinsider.com's Hot Lunchtime Reads 03/21: (ORCL) (GME) (AAPL) (GS) (JPM) (REGN)

Mar 21, 2012 10:49AM Baird Reiterates an 'Outperform' on Regeneron Pharma (REGN); View ACC As Coming Out Party

Feb 13, 2012 04:12PM Baird Reiterates an 'Outperform' on Regeneron Pharma (REGN); EYLEA Train Keeps On Rollin'....Raising Numbers Again

Feb 7, 2012 07:32AM Baird Reiterates an 'Outperform' on Regeneron Pharma (REGN); Think This Stock Still Has Legs

Jan 10, 2012 10:51AM Morning Movers 01/10: (VOXX) (FRAN) (CRL) (LULU) Higher; (WBMD) (HMA) (HITK) (LIZ) Lower

Jan 10, 2012 09:16AM Regeneron (REGN) Surges On Strong Initial Eylea Uptake

Jan 10, 2012 07:16AM Baird Upgrades Regeneron Pharma (REGN) to Outperform, Sees Continued Upside On Strong Eylea Uptake

Dec 5, 2011 09:32AM Baird Reiterates a 'Neutral' on Regeneron Pharma (REGN); VIEW 2-Year Data Blurs EYLEA's Differentiation, As Expected

Nov 1, 2011 07:46AM Baird Riterates a 'Neutral' on Regeneron Pharma (REGN); Q311 Uneventful; Still Think Best Case Scenario Is Priced In

Oct 26, 2011 11:22AM Notable Analyst Rating Changes 10/26: (AMTD) (NFLX) (REGN) Upgraded; (HGSI) (FSLR) (MF) Downgraded

Oct 13, 2011 11:09AM Baird Maintains a 'Neutral' on Regeneron Pharma (REGN) Following Roche's Q311 Lucentis Update

Sep 30, 2011 08:18AM Baird Reiterates a 'Neutral' on Regeneron Pharma (REGN); Kills Us to Sit on the Fence, But New Survey Shows That's the Best Place

Aug 17, 2011 11:54AM Baird Maintains a 'Neutral' on Regeneron Pharma (REGN); Updating Model for EYLEA Delay; Remain Cautious

Jun 2, 2011 10:34AM Notable Analyst Rating Changes 06/02: (AFFX) (JNJ) (DV) Upgraded; (GIS) (ES) (SRE) Downgraded

Dec 20, 2010 12:31PM Baird Raises Price Target on Regeneron Pharma (REGN), Maintains Neutral Rating

Sep 24, 2008 07:54AM Baird Initiates Coverage on Regeneron (REGN) with a Neutral